Group I (Surgical clips) (n = 80) | Group II (Commercial clips) (n = 80) | P value | |
---|---|---|---|
Age n (%) | |||
< 40 years | 39 (50.6%) | 38 (49.9%) | 0.293 |
40–50 years | 27 (44.3%) | 34(55.7%) | |
> 50 years | 14 (63.6%) | 8(36.4%) | |
BMI n (%) | |||
Normal | 8 (80.0%) | 2 (20.0%) | 0.138 |
Overweight | 23 (46.0%) | 27 (54.0%) | |
Obese | 49 (49.0%) | 51 (51.0%) | |
Tumor size n (%) | |||
< 40 mm | 11 (44.0%) | 14 (56.0%) | 0.715 |
40–49 mm | 23 (56.1%) | 18 (43.9%) | |
50–59 mm | 26 (46.6%) | 30 (53.6%) | |
> 59 mm | 20 (52.6%) | 18 (47.4%) | |
Tumor site n (%) | |||
Central | 12 (54.6%) | 10 (45.4%) | 0.882 |
Lower Inner Quadrant | 6 (42.9%) | 8 (57.1%) | |
Lower Outer Quadrant | 7 (58.3%) | 5 (41.7%) | |
Upper Inner Quadrant | 11 (55.0%) | 9 (45.0%) | |
Upper Outer Quadrant | 44 (47.8%) | 48 (52.2%) | |
Clinical staging n (%) | |||
IIA | 10 (41.7%) | 14 (58.3%) | 0.701 |
IIB | 16 (45.7%) | 19 (54.3%) | |
IIIA | 27 (54.0%) | 23 (46.0%) | |
IIIB | 27 (52.9%) | 24 (47.1%) | |
Histopathological type n (%) | |||
Infiltrative ductal carcinoma | 64 (49.6%) | 65 (50.4%) | 0.841 |
Infiltrative Lobular carcinoma | 16 (51.6%) | 15 (48.4%) | |
Molecular Subtype n (%) | |||
HER-2 Positive | 25 (51.0%) | 24 (49.0%) | 0.980 |
Luminal-A | 20 (47.7%) | 22 (52.3%) | |
Luminal-B | 8 (53.3%) | 7(46.7%) | |
Triple Negative | 27 (50.0%) | 27 (50.0%) | |
ARC Classification n (%) | |||
A | 17 (51.5%) | 16 (48.5%) | 0.550 |
B | 25 (51.0%) | 24 (49.0%) | |
C | 34 (52.3%) | 31 (47.7%) | |
D | 4 (30.8%) | 9 (69.2%) |